We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

129 hedge funds and large institutions have $332M invested in Aerie Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $842K | Put options by funds: $211K

7% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 41

6% less funds holding

Funds holding: 137 → 129 (-8)

20% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 35

36% less capital invested

Capital invested by funds: $522M → $332M (-$190M)

Holders
129
Holders Change
-8
Holders Change %
-5.84%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
38
Reduced
41
Closed
35
Calls
$842K
Puts
$211K
Net Calls
+$631K
Net Calls Change
-$1.58M

Top Buyers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
+$24.9M
2
Morgan Stanley
Morgan Stanley
New York
+$19M
3
DM
Deerfield Management
New York
+$18M
4
Millennium Management
Millennium Management
New York
+$9.31M
5
CSS
Cubist Systematic Strategies
Connecticut
+$4.77M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$11.4M
2
William Blair Investment Management
William Blair Investment Management
Illinois
-$11.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$10.4M
4
ClearBridge Investments
ClearBridge Investments
New York
-$9.93M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
126
Daiwa Securities Group
Japan
$1K – – –
Carson Wealth (CWM LLC)
127
Carson Wealth (CWM LLC)
Nebraska
$1K +$827 +79 New
Manulife (Manufacturers Life Insurance)
128
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$169 +$3.11K +297 +1%
ClearBridge Investments
129
ClearBridge Investments
New York
– -$9.93M -871,200 Closed
FCM
130
Frontier Capital Management
Massachusetts
– -$4.55M -399,103 Closed
MGIM
131
M&G Investment Management
United Kingdom
– -$3.17K -287,982 Closed
Balyasny Asset Management
132
Balyasny Asset Management
Illinois
– -$3M -262,835 Closed
IHAM
133
Integral Health Asset Management
New York
– -$2.85M -250,000 Closed
Norges Bank
134
Norges Bank
Norway
– -$2.3M -201,601 Closed
Fidelity Investments
135
Fidelity Investments
Massachusetts
– -$2.12M -186,310 Closed
HA
136
Homestead Advisers
Virginia
– -$1.78M -155,838 Closed
Bank of Montreal
137
Bank of Montreal
Ontario, Canada
– -$1.66M -144,951 Closed
NIM
138
NXG Investment Management
Texas
– -$785K -68,869 Closed
Vontobel Holding
139
Vontobel Holding
Switzerland
– -$532K -46,655 Closed
MAM
140
Martingale Asset Management
Massachusetts
– -$374K -32,718 Closed
Truist Financial
141
Truist Financial
North Carolina
– -$332K -29,133 Closed
Susquehanna International Group
142
Susquehanna International Group
Pennsylvania
– -$298K -28,483 Closed
LPL Financial
143
LPL Financial
California
– -$304K -26,634 Closed
HighTower Advisors
144
HighTower Advisors
Illinois
– -$287K -25,481 Closed
Natixis Advisors
145
Natixis Advisors
Massachusetts
– -$271K -23,803 Closed
AIA
146
Angeles Investment Advisors
California
– -$163K -14,282 Closed
William Blair & Company
147
William Blair & Company
Illinois
– -$155K -13,623 Closed
M&T Bank
148
M&T Bank
New York
– -$149K -13,132 Closed
Handelsbanken Fonder
149
Handelsbanken Fonder
Sweden
– -$149K -13,051 Closed
DekaBank Deutsche Girozentrale
150
DekaBank Deutsche Girozentrale
Germany
– -$136K -12,100 Closed
3 4 5
6
7

AERI Hedge Fund Activity: Q4 2021 in Review

129 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2021, worth a combined $332M — down 36% from $522M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of AERI and 28 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 38 added.

The largest buyer was Jefferies Group, opening a new position worth an estimated $24.9M. The largest seller was PFM Health Sciences, cutting an estimated $11.4M.

  • 129 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2021, down from 137 in Q3 2021.
  • Funds reported $332M of Aerie Pharmaceuticals stock for Q4 2021, down 36% quarter-over-quarter.
  • 28 funds opened new Aerie Pharmaceuticals positions in Q4 2021 and 35 closed out, a net change of -7 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2021 was Jefferies Group, an estimated $24.9M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2021 was PFM Health Sciences, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.